The present authors carried out an open up-label pilot study that administered psilocybin to 15 remedy-resistant tobacco/nicotine-dependent people who smoke, from the context of cognitive behavioral therapy for using tobacco cessation [58]. Contributors were administered ~0.29 mg/kg oral psilocybin around the participant’s concentrate on day to G